Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL)

被引：1
|
作者：
Li, He [1 ]
Zhang, Wanhua [1 ]
Yi, Dongni [1 ]
Ye, Yuanxin [2 ]
Xiao, Xueqiu [3 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Hematol, Hematol Res Lab, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
[3] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 04期
关键词：
CHRONIC MYELOID-LEUKEMIA; BCR-ABL; CLINICAL IMPACT; IMATINIB; RESISTANT; THERAPY;
D O I：
10.1080/10428194.2016.1225205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1005 / 1007
页数：3
相关论文
共 50 条
  • [41] High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph plus ALL TKI-SCT Study
    Nishiwaki, Satoshi
    Sugiura, Isamu
    Fujisawa, Shin
    Hatta, Yoshihiro
    Atsuta, Yoshiko
    Doki, Noriko
    Kurahashi, Shingo
    Ueda, Yasunori
    Dobashi, Nobuaki
    Maeda, Tomoya
    Taniguchi, Yasuhiro
    Tanaka, Masatsugu
    Kako, Shinichi
    Ichinohe, Tatsuo
    Fukuda, Takahiro
    Ohtake, Shigeki
    Ishikawa, Yuichi
    Kiyoi, Hitoshi
    Matsumura, Itaru
    Miyazaki, Yasushi
    HEMASPHERE, 2023, 7 (06):
  • [42] Dasatinib: A tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
    Steinberg, Michael
    CLINICAL THERAPEUTICS, 2007, 29 (11) : 2289 - 2308
  • [43] Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?
    Short, Nicholas J.
    Kantarjian, Hagop
    Jabbour, Elias
    Ravandi, Farhad
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (03) : 193 - 200
  • [44] A novel BCR-ABL1 mutation in a patient with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia
    Vinhas, Raquel
    Lourenco, Alexandra
    Santos, Susana
    Lemos, Marcos
    Ribeiro, Patricia
    de Sousa, Aida Botelho
    Baptista, Pedro Viana
    Fernandes, Alexandra Ramos
    ONCOTARGETS AND THERAPY, 2018, 11 : 8589 - 8598
  • [45] Effect of Prophylactic Post-transplant Ponatinib Administration on Outcomes in Patients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
    Nanno, Satoru
    Matsumoto, Kana
    Nakamae, Mika
    Okamura, Hiroshi
    Nishimoto, Mitsutaka
    Hirose, Asao
    Koh, Hideo
    Nakashima, Yasuhiro
    Nakane, Takahiko
    Morita, Kunihiko
    Hino, Masayuki
    Nakamae, Hirohisa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (12) : 813 - +
  • [46] Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph plus ALL
    Short, Nicholas J.
    Kantarjian, Hagop
    Kanagal-Shamanna, Rashmi
    Sasaki, Koji
    Ravandi, Farhad
    Cortes, Jorge
    Konopleva, Marina
    Issa, Ghayas C.
    Kornblau, Steven M.
    Garcia-Manero, Guillermo
    Garris, Rebecca
    Higgins, Jake
    Pratt, Gabriel
    Williams, Lindsey N.
    Valentine, Charles C., III
    Rivera, Victor M.
    Pritchard, Justin
    Salk, Jesse J.
    Radich, Jerald
    Jabbour, Elias
    BLOOD CANCER JOURNAL, 2020, 10 (05)
  • [47] A Boy Safely Treated with Tyrosine Kinase Inhibitors for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Osteolysis
    Shiwaku, Takahiro
    Ishida, Hisashi
    Tatebe, Yasuhisa
    Tamefusa, Kosuke
    Ochi, Motoharu
    Fujiwara, Kaori
    Kubo, Toshihide
    Nakata, Eiji
    Washio, Kana
    Tsukahara, Hirokazu
    ACTA MEDICA OKAYAMA, 2023, 77 (04) : 439 - 442
  • [48] Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Hijiya, Nobuko
    Zwaan, C. Michel
    Rizzari, Carmelo
    Foa, Robin
    Abbink, Floor
    Lancaster, Donna
    Landman-Parker, Judith
    Millot, Frederic
    Moppett, John
    Nelken, Brigitte
    Putti, Maria Caterina
    Tian, Xianbin
    Sinclair, Karen
    Santanastasio, Helene
    Buchbinder, Aby
    Kearns, Pamela
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 812 - 820
  • [49] Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemia
    Stock, Wendy
    Martinelli, Giovanni
    Stelljes, Matthias
    DeAngelo, Daniel J.
    Goekbuget, Nicola
    Advani, Anjali S.
    O'Brien, Susan
    Liedtke, Michaela
    Merchant, Akil A.
    Cassaday, Ryan D.
    Wang, Tao
    Zhang, Hui
    Vandendries, Erik
    Jabbour, Elias
    Marks, David, I
    Kantarjian, Hagop M.
    CANCER, 2021, 127 (06) : 905 - 913
  • [50] Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia
    Boulos, Nidal
    Mulder, Heather L.
    Calabrese, Christopher R.
    Morrison, Jeffrey B.
    Rehg, Jerold E.
    Relling, Mary V.
    Sherr, Charles J.
    Williams, Richard T.
    BLOOD, 2011, 117 (13) : 3585 - 3595
12345